Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

AstraZeneca, Daiichi Sankyo Launch Reflux Esophagitis App

By R&D Editors | September 19, 2013

After registering the drugs they are taking, the app lets users set alarms to prevent forgetting their medication. (Source: Daiichi Sankyo)Daiichi Sankyo Co. Ltd. and AstraZeneca K.K. are working to educate the public about reflux esophagitis through a campaign entitled “Do you experience heartburn or acid reflux?” The awareness building effort seeks to ensure an accurate understanding of the symptoms of reflux esophagitis and how they affect the daily lives of patients. The campaign incorporates a variety of media featuring TV commercials and a website to encourage patients to seek the appropriate treatment and take control of their lives.
 
In conjunction with this campaign, the companies have launched the new “Heartburn/Acid Reflux Notebook” iPhone app, only available in Japanese, which features a variety of functions to help patients relieve their symptoms.
 
Key features include:
  • Symptom checker: Users can easily record symptoms of heartburn and acid reflux, such as sleep disorder and others. They can also keep notes about their physical condition, troublesome symptoms and questions for their doctor at their next consultation.
  • Medication checker: After registering the drugs they are taking, this tool allows users to set alarms to prevent forgetting their medication and for future hospital visit dates. It also helps users see the decline in reflux esophagitis symptoms.
  • Photo meal diary: This feature allows users to record the number of meals they eat in a day and save photos along with the meal content. In addition to serving as a resource for patients to remember what they ate, physicians can also utilize the information when providing dietary advice.
  • Graph of heartburn and acid reflux symptoms: Progress of heartburn and acid reflux symptoms are saved and the corresponding loss of sleep can be checked in daily and weekly increments. This makes it possible to explain changes in the user’s symptoms to physicians at the time of examination.
 
Japan’s recent shift towards a western diet and lowered incidence of helicobacter pylori infection have resulted in increased levels of acid secretion and reflux esophagitis sufferers are thought to be on the rise. Reflux esophagitis is a disease in which inflammation of the esophageal membrane occurs when stomach contents, including the highly acidic hydrochloric acid (gastric acid), are regurgitated. The main symptoms of the disease include heartburn and acid reflux (an acidic taste in the throat and mouth, accompanied by a feeling that the contents of the stomach are being regurgitated). The Japanese Society of Gastroenterology’s 2009 GERD treatment guidelines state that one or more instances of symptoms per week have a negative effect on QOL, and that the ultimate goal is to relieve symptoms completely.
 
Daiichi Sankyo and AstraZeneca aim to educate the public about this disease through a variety of media including this iPhone app to help patients take control their lives.
 
Date: September
Source: Daiichi Sankyo

Related Articles Read More >

Who’s building in pharma, and who would be spared from 100% tariffs, if enacted
2025 R&D layoffs tracker: hardware and chips lead the year’s biggest cuts while biopharma pares pipelines
Skin’s built-in “stretch sensor” helps tissue grow in mouse study
Meissner launches rotary impeller mixing solutions (RMS) portfolio for biocontainer mixing
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE